Form 4 holding
10%+ Owner
BioXcel Therapeutics, Inc.
- Security class
- Common Stock
- Shares / value
- 8,546,750
- Estimated value
- $187,088,358
- Report date
- 03 Apr 2023
- Price
- $21.89
- Ownership
- By BioXcel LLC
Michael James Aiello
Insider Reports History
- Reporting-owner location
- Wallingford, CT
- Latest reporting-owner signature
- /s/ Michael James Aiello
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for Michael James Aiello
Insider Reports Filed by Michael James Aiello
3
BTAI
BioXcel Therapeutics, Inc.
- Report period
- 03 Apr 2023
- Transactions
- 0
- Transaction value
- $0
- Accepted by SEC
- 26 Apr 2023, 15:19
- Role
- 10%+ Owner
- Next action
- Open filing details